Interdisziplinärer Arbeitskreis Bewegungsstörungen
Randomized trial of botulinum toxin to prevent pes cavus progression in pediatric charcot-marie-tooth disease type 1A: Burns J et al.
Musscle Nerve 42: 262–267, 2010
Autoren:
JOSHUA BURNS, PhD, 1,2
ADAM SCHEINBERG, MMed, 3,4
MONIQUE M. RYAN, MMed, 5
KRISTY J. ROSE, MHSc, 2
and ROBERT A. OUVRIER, MD, 2
Autoren-Details:
1 Faculty of Health Sciences, University of Sydney, Sydney, New South Wales, Australia
2 Institute for Neuroscience and Muscle Research, Children’s Hospital at Westmead, Locked Bag 4001, Sydney,New South Wales 2145, Australia
3 Department of Rehabilitation, The Children’s Hospital at Westmead, Sydney, New South Wales, Australia
4 Victorian Paediatric Rehabilitation Service, Victoria, Australia
5 Children’s Neuroscience Centre, Royal Children’s Hospital/Murdoch Children’s Research Institute/Department of Paediatrics,Faculty of Medicine, University of Melbourne, Victoria, Australia